CeramTec GmbH Medical Products Division
FDA inspection history on file, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483.
Cited most
Across all CeramTec GmbH Medical Products Division observations on file
- 21 CFR 803.17What are the requirements for developing, maintaining, and implementing written MDR procedures that apply to me?1
- 21 CFR 820.75Process validation1
The complete CeramTec GmbH Medical Products Division file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-01-19 | 483 Form 483 | — | 2 | $99 |
FEI number 3001278222 · most recent document Jan 19, 2023
About CeramTec GmbH Medical Products Division
How many FDA Form 483s has CeramTec GmbH Medical Products Division received?
FDA Intel has 1 Form 483 on file for CeramTec GmbH Medical Products Division; the most recent is dated Jan 19, 2023.
When was CeramTec GmbH Medical Products Division last inspected by FDA?
The most recent FDA inspection document on file for CeramTec GmbH Medical Products Division is a Form 483 dated Jan 19, 2023.
What did FDA cite at CeramTec GmbH Medical Products Division?
The regulations cited most in the observations on file for CeramTec GmbH Medical Products Division are 21 CFR 803.17 (What are the requirements for developing, maintaining, and implementing written MDR procedures that apply to me?), 1 time; 21 CFR 820.75 (Process validation), 1 time.